CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 235 filers reported holding CORCEPT THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,106 | +45.4% | 114 | +18.8% | 0.00% | – |
| Q2 2023 | $2,136 | -45.2% | 96 | -46.7% | 0.00% | – |
| Q1 2023 | $3,899 | +99.9% | 180 | +87.5% | 0.00% | – |
| Q4 2022 | $1,950 | -78.3% | 96 | -71.8% | 0.00% | -100.0% |
| Q3 2022 | $9,000 | +350.0% | 340 | +254.2% | 0.00% | – |
| Q2 2022 | $2,000 | 0.0% | 96 | 0.0% | 0.00% | – |
| Q1 2022 | $2,000 | -50.0% | 96 | -50.5% | 0.00% | -100.0% |
| Q4 2021 | $4,000 | +33.3% | 194 | +27.6% | 0.00% | 0.0% |
| Q3 2021 | $3,000 | -57.1% | 152 | -51.6% | 0.00% | -50.0% |
| Q2 2021 | $7,000 | +16.7% | 314 | +33.1% | 0.00% | +100.0% |
| Q1 2021 | $6,000 | +20.0% | 236 | +33.3% | 0.00% | 0.0% |
| Q4 2020 | $5,000 | +150.0% | 177 | +84.4% | 0.00% | 0.0% |
| Q3 2020 | $2,000 | +100.0% | 96 | +92.0% | 0.00% | – |
| Q2 2020 | $1,000 | 0.0% | 50 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 50 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INGALLS & SNYDER LLC | 6,911,376 | $155,644,000 | 6.95% |
| Parallel Advisors, LLC | 1,944,319 | $47,014,000 | 1.86% |
| TANAKA CAPITAL MANAGEMENT INC | 39,289 | $885,000 | 1.79% |
| S&T BANK/PA | 508,546 | $11,452,000 | 1.73% |
| Bridge City Capital, LLC | 83,967 | $1,891,000 | 0.88% |
| Birchview Capital, LP | 50,000 | $1,126,000 | 0.81% |
| Quantedge Capital Pte Ltd | 113,012 | $2,545,000 | 0.75% |
| FAS Wealth Partners, Inc. | 289,625 | $6,522,000 | 0.61% |
| AJ WEALTH STRATEGIES, LLC | 396,029 | $8,919,000 | 0.44% |
| TRUSTCORE FINANCIAL SERVICES, LLC | 208,806 | $4,702,000 | 0.41% |